Prescription Required
Letroz 2.5 mg Tablet is a medication primarily used in the treatment of breast cancer in postmenopausal women. It belongs to the class of drugs known as aromatase inhibitors, which help reduce estrogen levels in the body, slowing or stopping the growth of estrogen-dependent cancer cells. Manufactured by trusted pharmaceutical brands, Letroz is a widely prescribed choice for managing and preventing the recurrence of breast cancer.
While there is no direct interaction between Letroz and alcohol, consuming alcohol may worsen side effects like dizziness or fatigue.
Letroz 2.5mg Tablet is contraindicated during pregnancy as it may harm the developing baby.
Letroz is not recommended for breastfeeding mothers, as it may pass into breast milk and affect the infant.
Patients with severe kidney problems should consult their doctor before taking Letroz. Dosage adjustments may be required based on kidney function.
Letroz is processed in the liver, so it should be used with caution in patients with liver conditions.
Letroz can sometimes cause dizziness, fatigue, or drowsiness. Avoid driving or operating heavy machinery if you feel unwell or unable to concentrate.
The active ingredient in Letroz, Letrozole, works by blocking an enzyme called aromatase. This enzyme is responsible for converting certain hormones (androgens) into estrogen. By lowering estrogen levels in the body, Letroz reduces the hormone that some breast cancer cells need to grow, helping to slow down or stop the growth of hormone-sensitive breast cancer.
If you miss a dose:
Breast cancer occurs when abnormal cells in the breast grow uncontrollably. Hormone receptor-positive breast cancer, the most common type, is driven by estrogen or progesterone hormones. Treatments like Letroz work by blocking the hormonal pathways that fuel cancer growth.
Content Updated on
Wednesday, 22 January, 2025Prescription Required
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHA